Organon Future Growth

Future criteria checks 1/6

Organon's revenue and earnings are forecast to decline at 0.06% and 7.1% per annum respectively. EPS is expected to decline by 7.4% per annum. Return on equity is forecast to be 84.3% in 3 years.

Key information

-7.1%

Earnings growth rate

-7.4%

EPS growth rate

Pharmaceuticals earnings growth19.6%
Revenue growth rate-0.06%
Future return on equity84.3%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0A9W - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,5291,0251,1031,0786
12/31/20256,5288711,0339837
12/31/20246,3999157011,1296
9/30/20246,4091,301646946N/A
6/30/20246,3461,0007871,066N/A
3/31/20246,3471,047458761N/A
12/31/20236,2631,023538799N/A
9/30/20236,150585424669N/A
6/30/20236,168754320725N/A
3/31/20236,145746431849N/A
12/31/20226,174917431858N/A
9/30/20226,2921,011138638N/A
6/30/20226,3551,107343689N/A
3/31/20226,3651,3045641,077N/A
12/31/20216,3041,3511,9702,458N/A
9/30/20216,3141,5252,3702,841N/A
6/30/20216,3271,7622,3042,761N/A
3/31/20216,2581,9172,7723,025N/A
12/31/20206,5322,2561,9322,187N/A
12/31/20197,7773,3062,6752,767N/A
12/31/20189,7772,1533,5863,687N/A
12/31/201710,5001,801N/A3,419N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0A9W's earnings are forecast to decline over the next 3 years (-7.1% per year).

Earnings vs Market: 0A9W's earnings are forecast to decline over the next 3 years (-7.1% per year).

High Growth Earnings: 0A9W's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 0A9W's revenue is expected to decline over the next 3 years (-0.06% per year).

High Growth Revenue: 0A9W's revenue is forecast to decline over the next 3 years (-0.06% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0A9W's Return on Equity is forecast to be very high in 3 years time (84.3%).


Discover growth companies